| Year |
Citation |
Score |
| 2024 |
Murthy D, Attri KS, Suresh V, Rajacharya GH, Valenzuela CA, Thakur R, Zhao J, Shukla SK, Chaika NV, LaBreck D, Rao CV, Hollingsworth MA, Mehla K, Singh PK. The MUC1-HIF-1α signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling. Proceedings of the National Academy of Sciences of the United States of America. 121: e2315509121. PMID 38547055 DOI: 10.1073/pnas.2315509121 |
0.325 |
|
| 2023 |
Madka V, Patlolla JMR, Venkatachalam K, Zhang Y, Pathuri G, Stratton N, Lightfoot S, Janakiram NB, Mohammed A, Rao CV. Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats. Cancers. 15. PMID 37568816 DOI: 10.3390/cancers15154001 |
0.445 |
|
| 2022 |
Madka V, De La Cruz A, Pathuri G, Panneerselvam J, Zhang Y, Stratton N, Hacking S, Finnberg NK, Safran HP, Sei S, Glaze ER, Shoemaker R, Fox JT, Raufi AG, El-Deiry WS, ... Rao CV, et al. Oral administration of TRAIL-inducing small molecule ONC201/TIC10 prevents intestinal polyposis in the mouse model. American Journal of Cancer Research. 12: 2118-2131. PMID 35693092 |
0.328 |
|
| 2021 |
Kumar G, Madka V, Pathuri G, Ganta V, Rao CV. Molecular Mechanisms of Cancer Prevention by Gooseberry (). Nutrition and Cancer. 1-12. PMID 34839775 DOI: 10.1080/01635581.2021.2008988 |
0.329 |
|
| 2021 |
Madka V, Kumar G, Pathuri G, Panneerselvam J, Zhang Y, Ganta V, Lightfoot S, Lubet RA, Suen CS, Steele VE, Janakiram NB, Mohammed A, Rao CV. Proton pump inhibitor omeprazole suppresses carcinogen induced colonic adenoma progression to adenocarcinoma in F344 rat. Cancer Prevention Research (Philadelphia, Pa.). PMID 34341012 DOI: 10.1158/1940-6207.CAPR-21-0057 |
0.389 |
|
| 2021 |
Kumar G, Madka V, Singh A, Farooqui M, Stratton N, Lightfoot S, Mohammed A, Rao CV. Naproxen inhibits spontaneous lung adenocarcinoma formation in Kras mice. Neoplasia (New York, N.Y.). 23: 574-583. PMID 34091121 DOI: 10.1016/j.neo.2021.05.010 |
0.341 |
|
| 2020 |
Xiong X, Rao G, Roy RV, Zhang Y, Means N, Dey A, Tsaliki M, Saha S, Bhattacharyya S, Dhar Dwivedi SK, Rao CV, McCormick DJ, Dhanasekaran D, Ding K, Gillies E, et al. Ubiquitin-binding associated protein 2 regulates KRAS activation and macropinocytosis in pancreatic cancer. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 32692445 DOI: 10.1096/Fj.201902826Rr |
0.414 |
|
| 2020 |
Panneerselvam J, Mohandoss P, Patel R, Gillan H, Li M, Kumar K, Nguyen D, Weygant N, Qu D, Pitts K, Lightfoot S, Rao C, Houchen C, Bronze M, Chandrakesan P. DCLK1 Regulates Tumor Stemness and Cisplatin Resistance in Non-small Cell Lung Cancer via ABCD-Member-4. Molecular Therapy Oncolytics. 18: 24-36. PMID 32637578 DOI: 10.1016/J.Omto.2020.05.012 |
0.405 |
|
| 2020 |
Chandrakesan P, Panneerselvam J, May R, Weygant N, Qu D, Berry WR, Pitts K, Stanger BZ, Rao CV, Bronze MS, Houchen CW. DCLK1-isoform2 alternative splice variant promotes pancreatic tumor immunosuppressive M2-macrophage polarization. Molecular Cancer Therapeutics. PMID 32371580 DOI: 10.1158/1535-7163.Mct-19-0776 |
0.317 |
|
| 2020 |
Yarla NS, Pathuri G, Gali H, Madka V, Panneerselvam J, Chandrakesan P, Houchen CW, Glaze ER, Fox J, McCormick D, Rao CV. Abstract 6364: LFA-9, a dual mPGES-1 and 5-LOX inhibitor, suppresses colon cancer stemness and inflammogen-induced inflammatory response Cancer Research. 80: 6364-6364. DOI: 10.1158/1538-7445.Am2020-6364 |
0.469 |
|
| 2020 |
Chandrakesan P, Panneerselvam J, Qu D, Rao C, Bronze M, Houchen C. Abstract 3829: Dclk1 expressing crypt epithelial cells become tumor initiating stem cells in an inflammation associated environment Tumor Biology. DOI: 10.1158/1538-7445.Am2020-3829 |
0.334 |
|
| 2020 |
Mohammed A, Madka V, Kumar G, Singh A, Stratton N, Lightfoot S, Miller MS, Rao CV. Abstract 13: Aspirin and metformin combination inhibits PDAC progression and metastasis in KPC mice Cancer Research. 80: 13-13. DOI: 10.1158/1538-7445.Am2020-13 |
0.487 |
|
| 2020 |
Kumar G, Madka V, Singh A, Kumar N, Stratton N, Lightfoot S, Mohammed A, Miller MS, Rao CV. Abstract 1102: Model optimization and chemoprevention of IPMN driven PDAC in KPSD4 mouse model Cancer Research. 80: 1102-1102. DOI: 10.1158/1538-7445.Am2020-1102 |
0.401 |
|
| 2019 |
Madka V, Kumar G, Pathuri G, Zhang Y, Lightfoot S, Asch AS, Mohammed A, Steele VE, Rao CV. Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-induced Colon Cancer in F344 Rat Model. Cancer Prevention Research (Philadelphia, Pa.). PMID 31699708 DOI: 10.1158/1940-6207.Capr-19-0265 |
0.55 |
|
| 2019 |
Mohammed A, Janakiram NB, Madka V, Zhang Y, Singh A, Biddick L, Li Q, Lightfoot S, Steele VE, Lubet RA, Suen CS, Miller MS, Sei S, Rao CV. Intermittent dosing regimens of aspirin and naproxen inhibit azoxymethane-induced colon adenoma progression to adenocarcinoma and invasive carcinoma. Cancer Prevention Research (Philadelphia, Pa.). PMID 31530543 DOI: 10.1158/1940-6207.Capr-19-0312 |
0.492 |
|
| 2019 |
Mohammed A, Janakiram NB, Suen C, Stratton N, Lightfoot S, Singh A, Pathuri G, Ritchie R, Madka V, Rao CV. Targeting cholecystokinin-2 receptor for pancreatic cancer chemoprevention. Molecular Carcinogenesis. PMID 31313401 DOI: 10.1002/Mc.23084 |
0.465 |
|
| 2019 |
Mohammed A, Janakiram NB, Suen C, Stratton N, Lightfoot S, Singh A, Pathuri G, Ritchie R, Madka V, Rao CV. Abstract 5079: Targeting cholecystokinin-2 receptor (CCK2R) for pancreatic ductal adenocarcinoma prevention in p48Cre/+-LSL-KrasG12D/+mice model Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-5079 |
0.324 |
|
| 2019 |
Houchen C, Panneerselvam J, Mohandoss P, Weygant N, May R, Qu D, Ali N, Wang T, Rao C, Bronze M, Chandrakesan P. Abstract 2119: DCLK1 regulates ATR-DNA damage response for KRAS mutant lung cancer drug resistance and stemness Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2119 |
0.301 |
|
| 2019 |
Kumar G, Madka V, Logsdon C, Singh A, Stratton N, Lightfoot S, Mohammed A, Rao CV. Abstract 5075: Naproxen blocks spontaneous lung adenoma progression to adenocarcinoma in Kras-G12Vmice Cancer Research. 79: 5075-5075. DOI: 10.1158/1538-7445.Am2019-5075 |
0.451 |
|
| 2019 |
Madka V, Zhang Y, Kumar N, Pathuri G, Stratton N, Lightfoot S, Asch AS, Steele VE, Mohammed A, Rao CV. Abstract 5065: Pharmacological modulation of inflammation and p53 signaling synergize to prevents muscle invasive bladder cancerin-vivo Cancer Research. 79: 5065-5065. DOI: 10.1158/1538-7445.Am2019-5065 |
0.491 |
|
| 2018 |
Kumar G, Farooqui M, Rao CV. Role of Dietary Cancer-Preventive Phytochemicals in Pancreatic Cancer Stem Cells. Current Pharmacology Reports. 4: 326-335. PMID 30560046 DOI: 10.1007/S40495-018-0145-2 |
0.437 |
|
| 2018 |
Yarla NS, Gali H, Pathuri G, Smriti S, Madka V, Panneerselvam J, Kumar G, Farooqui M, Rao CV. Targeting the Paracrine Hormone-Dependent Guanylate cyclase/cGMP/Phosphodiesterases Signaling Pathway for Colorectal Cancer Prevention. Seminars in Cancer Biology. PMID 30189250 DOI: 10.1016/J.Semcancer.2018.08.011 |
0.425 |
|
| 2018 |
Mohammed A, Yarla NS, Madka V, Rao CV. Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives. International Journal of Molecular Sciences. 19. PMID 30096840 DOI: 10.3390/Ijms19082332 |
0.413 |
|
| 2018 |
Mohammed A, Rao CV. Pancreatic Cancer Chemoprevention: Challenges and Opportunities. Current Medicinal Chemistry. 25: 2532-2534. PMID 30014794 DOI: 10.2174/092986732522180704091601 |
0.407 |
|
| 2018 |
Rao CV. Immunomodulatory Effects ofExtract in the Prevention of Oral Cancer. Cancer Prevention Research (Philadelphia, Pa.). PMID 29559516 DOI: 10.1158/1940-6207.Capr-17-0379 |
0.414 |
|
| 2018 |
Rao CV, Mohammed A, Janakiram NB. Abstract B42: Safer approaches to colorectal cancer chemoprevention Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Tcm17-B42 |
0.542 |
|
| 2018 |
Janakiram NB, Madka V, Zhang Y, Stratton N, Bezawada H, Griesel B, Mohammed A, Olson AL, Rao CV. Abstract 4984: Celastrol inhibits high fat diet-induced obesity and intestinal tumorigenesis in APCMin/+ mice by modulating gut microbes and inflammation Cancer Research. 78: 4984-4984. DOI: 10.1158/1538-7445.Am2018-4984 |
0.495 |
|
| 2018 |
Mohammed A, Janakiram NB, Madka V, Zhang Y, Singh A, Biddick L, Li Q, Lightfoot S, Steele VE, Lubet R, Miller MS, Suen CS, Sei S, Rao CV. Abstract 4983: Intermittent dosing regimens of naproxen and aspirin inhibit azoxymethane-induced rat colon adenoma progression to adenocarcinoma and carcinoma invasion Prevention and Research. DOI: 10.1158/1538-7445.Am2018-4983 |
0.376 |
|
| 2018 |
Madka V, Raju J, Pathuri G, Smriti S, Bao A, Zhang Y, Stratton N, Farooqui M, Lightfoot S, Asch AS, Rao CV. Abstract 1269: Diosgenin, a naturally occurring steroidal saponin, prevents colon cancer in animal models of hereditary and sporadic CRC Prevention and Research. DOI: 10.1158/1538-7445.Am2018-1269 |
0.434 |
|
| 2017 |
Benbrook DM, Janakiram NB, Chandra V, Pathuri G, Madka V, Stratton NC, Masamha CP, Farnsworth CN, Garcia-Contreras L, Hatipoglu MK, Lighfoot S, Rao CV. Development of a dietary formulation of the SHetA2 chemoprevention drug for mice. Investigational New Drugs. PMID 29273857 DOI: 10.1007/S10637-017-0550-0 |
0.4 |
|
| 2017 |
Mohammed A, Janakiram NB, Madka V, Pathuri G, Li Q, Ritchie R, Biddick L, Kutche H, Zhang Y, Singh A, Gali H, Lightfoot S, Steele VE, Suen CS, Rao CV. Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer. Oncotarget. 8: 97822-97834. PMID 29228654 DOI: 10.18632/Oncotarget.22085 |
0.482 |
|
| 2017 |
Rao CV, Pal S, Mohammed A, Farooqui M, Doescher MP, Asch AS, Yamada HY. Biological effects and epidemiological consequences of arsenic exposure, and reagents that can ameliorate arsenic damage in vivo. Oncotarget. 8: 57605-57621. PMID 28915699 DOI: 10.18632/Oncotarget.17745 |
0.359 |
|
| 2017 |
Janakiram NB, Mohammed A, Bryant T, Ritchie R, Stratton N, Jackson L, Lightfoot S, Benbrook DM, Asch A, Lang ML, Rao CV. Loss of natural killer T (NKT) cells promotes pancreatic cancer in LSL-Kras(G12D/+) mice. Immunology. PMID 28419443 DOI: 10.1111/Imm.12746 |
0.43 |
|
| 2017 |
Rao C, Mohammed A, Asch A, Janakiram N. Immunoprevention of Pancreatic Cancer. Current Medicinal Chemistry. PMID 28240168 DOI: 10.2174/0929867324666170223153509 |
0.329 |
|
| 2017 |
Mohammed A, Janakiram NB, Madka V, Li M, Asch AS, Rao CV. Current Challenges and Opportunities for Chemoprevention of Pancreatic Cancer. Current Medicinal Chemistry. PMID 28183260 DOI: 10.2174/0929867324666170209104453 |
0.415 |
|
| 2017 |
Janakiram NB, Mohammed A, Patlolla JMR, Zhang Y, Biddick L, Madka V, Qian L, Lightfoot S, Dunn B, Lubet R, Suen CS, Steele VE, Rao CV. Abstract 5260: NGS Transcriptome analysis of colon adenocarcinomas treated with individual and combination of aspirin and omeprazole Cancer Research. 77: 5260-5260. DOI: 10.1158/1538-7445.Am2017-5260 |
0.517 |
|
| 2017 |
Mohammed A, Janakiram NB, Madka V, Kumar G, Edgar S, Pathuri G, Bryant T, Zhang Y, Gali H, Zhao YD, Lightfoot S, Rao CV. Abstract 1159: Targeting novel mucin synthesis pathway for pancreatic cancer treatment Cancer Research. 77: 1159-1159. DOI: 10.1158/1538-7445.Am2017-1159 |
0.386 |
|
| 2017 |
Madka V, Asch AS, Rao CV. Targeting Inflammation for Bladder Cancer Chemoprevention Current Pharmacology Reports. 3: 447-457. DOI: 10.1007/S40495-017-0116-Z |
0.416 |
|
| 2016 |
Rao CV, Janakiram NB, Mohammed A. Molecular Pathways: Mucins and drug delivery in cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28039261 DOI: 10.1158/1078-0432.Ccr-16-0862 |
0.429 |
|
| 2016 |
Chandrakesan P, May R, Weygant N, Qu D, Berry WL, Sureban SM, Ali N, Rao C, Huycke M, Bronze MS, Houchen CW. Intestinal tuft cells regulate the ATM mediated DNA Damage response via Dclk1 dependent mechanism for crypt restitution following radiation injury. Scientific Reports. 6: 37667. PMID 27876863 DOI: 10.1038/Srep37667 |
0.314 |
|
| 2016 |
Janakiram NB, Mohammed A, Bryant T, Zhang Y, Brewer M, Duff A, Biddick L, Singh A, Lightfoot S, Steele VE, Rao CV. Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer. Scientific Reports. 6: 37046. PMID 27841323 DOI: 10.1038/Srep37046 |
0.524 |
|
| 2016 |
Rao CV, Asch AS, Yamada HY. Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer. Carcinogenesis. PMID 27838634 DOI: 10.1093/Carcin/Bgw118 |
0.347 |
|
| 2016 |
Rao CV, Asch AS, Yamada HY. Emerging links among Chromosome Instability (CIN), cancer, and aging. Molecular Carcinogenesis. PMID 27533343 DOI: 10.1002/Mc.22539 |
0.379 |
|
| 2016 |
Miller MS, Allen P, Brentnall TA, Goggins M, Hruban RH, Petersen GM, Rao CV, Whitcomb DC, Brand RE, Chari ST, Klein AP, Lubman DM, Rhim AD, Simeone DM, Wolpin BM, et al. Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report. Pancreas. 45: 1080-91. PMID 27518363 DOI: 10.1097/Mpa.0000000000000705 |
0.426 |
|
| 2016 |
Kumar G, Patlolla JM, Madka V, Mohammed A, Li Q, Zhang Y, Biddick L, Singh A, Gillaspy A, Lightfoot S, Steele VE, Kopelovich L, Rao CV. Simultaneous targeting of 5-LOX-COX and ODC block NNK-induced lung adenoma progression to adenocarcinoma in A/J mice. American Journal of Cancer Research. 6: 894-909. PMID 27293987 |
0.412 |
|
| 2016 |
Nguyen CB, Kotturi H, Waris G, Mohammed A, Chandrakesan P, May R, Sureban S, Weygant N, Qu D, Rao C, Dhanasekaran DN, Bronze MS, Houchen CW, Ali N. (Z)-3,5,4'-Trimethoxystilbene Limits Hepatitis C and Cancer Pathophysiology by Blocking Microtubule Dynamics and Cell Cycle Progression. Cancer Research. PMID 27287718 DOI: 10.1158/0008-5472.Can-15-2722 |
0.395 |
|
| 2016 |
Rao CV, Janakiram NB, Madka V, Kumar G, Edgar S, Pathuri G, Bryant T, Kutsche H, Zhang Y, Biddick L, Gali H, Zhao D, Lightfoot S, Mohammed A. Small molecule inhibition of GCNT3 disrupts mucin biosynthesis and malignant cellular behaviors in pancreatic cancer. Cancer Research. PMID 26880801 DOI: 10.1158/0008-5472.Can-15-2820 |
0.483 |
|
| 2016 |
Janakiram NB, Mohammed A, Madka V, Kumar G, Rao CV. Prevention and treatment of cancers by immune modulating nutrients. Molecular Nutrition & Food Research. PMID 26833775 DOI: 10.1002/Mnfr.201500884 |
0.341 |
|
| 2016 |
Rao CV, Sanghera S, Zhang Y, Biddick L, Reddy A, Lightfoot S, Janakiram NB, Mohammed A, Dai W, Yamada HY. Systemic Chromosome Instability Resulted in Colonic Transcriptomic Changes in Metabolic, Proliferation, and Stem Cell Regulators in Sgo1-/+ Mice. Cancer Research. 76: 630-42. PMID 26833665 DOI: 10.1158/0008-5472.Can-15-0940 |
0.488 |
|
| 2016 |
Mohammed A, Janakiram NB, Madka V, Pathuri G, Li Q, Ritchie R, Biddick L, Kutsche H, Zhang Y, Singh A, Gali H, Lightfoot S, Steele VE, Suen CS, Rao CV. Abstract 5255: Lack of chemopreventive effects of dietary P2×7R inhibitors against pancreatic cancer in p48Cre/+-LSL-KrasG12D/+ mice Cancer Research. 76: 5255-5255. DOI: 10.1158/1538-7445.Am2016-5255 |
0.465 |
|
| 2016 |
Madka V, Mohammed A, Li Q, Zhang Y, Lightfoot S, Wu X, Steele V, Kopelovich L, Rao CV. Abstract 5241: Nitric oxide-releasing naproxen prevents muscle invasive bladder cancer Cancer Research. 76: 5241-5241. DOI: 10.1158/1538-7445.Am2016-5241 |
0.5 |
|
| 2016 |
Kumar G, Patolla JMR, Madka V, Mohammed A, Qian L, Zhang Y, Biddick L, Singh A, Gillaspy A, Lightfoot S, Kopelovich L, Steele VE, Rao CV. Abstract 2625: Simultaneous targeting of ODC and 5-LOX/COX block the tobacco carcinogen-induced lung adenoma progression to adenocarcinoma in A/J mice Cancer Research. 76: 2625-2625. DOI: 10.1158/1538-7445.Am2016-2625 |
0.502 |
|
| 2016 |
Mohammed A, Janakiram NB, Madka V, Kumar G, Edgar S, Pathuri G, Bryant T, Kutsche H, Zhang Y, Biddick L, Gali H, Zhao YD, Lightfoot S, Rao CV. Abstract 2621: Disruption of mucin synthesis by targeting GCNT3 inhibits pancreatic cancer progression Cancer Research. 76: 2621-2621. DOI: 10.1158/1538-7445.Am2016-2621 |
0.438 |
|
| 2016 |
Janakiram NB, Mohammed A, Pathuri G, Madka V, Ritchie R, Bryant T, Zhang Y, Li Q, Lightfoot S, Gali H, Vernon SE, Suen CS, Rao CV. Abstract 2604: Chemoprevention of colorectal cancer by LFA-9, a novel dual mPGES-1/5-LOX inhibitor: safer approaches to chemoprevention Cancer Research. 76: 2604-2604. DOI: 10.1158/1538-7445.Am2016-2604 |
0.571 |
|
| 2015 |
Madka V, Mohammed A, Li Q, Zhang Y, Kumar G, Lightfoot S, Wu X, Steele V, Kopelovich L, Rao CV. TP53 modulating agent, CP-31398 enhances antitumor effects of ODC inhibitor in mouse model of urinary bladder transitional cell carcinoma. American Journal of Cancer Research. 5: 3030-41. PMID 26693057 |
0.365 |
|
| 2015 |
Madka V, Mohammed A, Li Q, Zhang Y, Biddick L, Patlolla JM, Lightfoot S, Towner RA, Wu XR, Steele VE, Koplevich L, Rao CV. Targeting mTOR and p53 signaling inhibits muscle invasive bladder cancer in vivo. Cancer Prevention Research (Philadelphia, Pa.). PMID 26577454 DOI: 10.1158/1940-6207.Capr-15-0199 |
0.498 |
|
| 2015 |
Rao CV, Janakiram NB, Madka V, Devarkonda V, Brewer M, Biddick L, Lightfoot S, Steele VE, Mohammed A. Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma. Oncotarget. PMID 26429877 DOI: 10.18632/Oncotarget.5396 |
0.496 |
|
| 2015 |
Patlolla JM, Kopelovich L, Qian L, Zhang Y, Kumar G, Madka V, Mohammed A, Biddick L, Sadeghi M, Lightfoot S, Rao CV. Early and delayed intervention with Rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice. Oncology Reports. PMID 26397133 DOI: 10.3892/Or.2015.4277 |
0.437 |
|
| 2015 |
Mohammed A, Janakiram NB, Pant S, Rao CV. Molecular Targeted Intervention for Pancreatic Cancer. Cancers. 7: 1499-542. PMID 26266422 DOI: 10.3390/Cancers7030850 |
0.413 |
|
| 2015 |
Janakiram NB, Mohammed A, Rao CV. Sea Cucumbers Metabolites as Potent Anti-Cancer Agents. Marine Drugs. 13: 2909-23. PMID 25984989 DOI: 10.3390/Md13052909 |
0.355 |
|
| 2015 |
Rao CV, Mohammed A. New insights into pancreatic cancer stem cells. World Journal of Stem Cells. 7: 547-55. PMID 25914762 DOI: 10.4252/Wjsc.V7.I3.547 |
0.453 |
|
| 2015 |
Mohammed A, Janakiram NB, Madka V, Brewer M, Ritchie RL, Lightfoot S, Kumar G, Sadeghi M, Patlolla JM, Yamada HY, Cruz-Monserrate Z, May R, Houchen CW, Steele VE, Rao CV. Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression. Oncotarget. 6: 15524-39. PMID 25906749 DOI: 10.18632/Oncotarget.3499 |
0.489 |
|
| 2015 |
Rao CV, Sanghera S, Zhang Y, Biddick L, Reddy A, Lightfoot S, Dai W, Yamada HY. Antagonizing pathways leading to differential dynamics in colon carcinogenesis in Shugoshin1 (Sgo1)-haploinsufficient chromosome instability model. Molecular Carcinogenesis. PMID 25773652 DOI: 10.1002/Mc.22306 |
0.524 |
|
| 2015 |
Janakiram NB, Mohammed A, Bryant T, Lightfoot S, Collin PD, Steele VE, Rao CV. Improved innate immune responses by Frondanol A5, a sea cucumber extract, prevent intestinal tumorigenesis. Cancer Prevention Research (Philadelphia, Pa.). 8: 327-37. PMID 25657017 DOI: 10.1158/1940-6207.Capr-14-0380 |
0.415 |
|
| 2015 |
Madka V, Mohammed A, Li Q, Zhang Y, Biddick L, Patlolla JMR, Lightfoot S, Wu X, Steele V, Kopelovich L, Rao CV. Abstract 4653: Modulation of mTOR and p53 signaling using rapamycin plus CP-31398 inhibits growth and progression of urothelial carcinoma in-vivo Cancer Research. 75: 4653-4653. DOI: 10.1158/1538-7445.Am2015-4653 |
0.511 |
|
| 2015 |
Janakiram NB, Mohammed A, Bryant T, Ritchie R, Pathuri G, Lightfoot S, Lang ML, Rao CV. Abstract 3179: Enhanced pancreatic tumor progression in p48Cre-KrasG12D mice is regulated by natural killer T (NKT) cells dependent on mPGES-1 in tumor-associated macrophages Immunology. 75: 3179-3179. DOI: 10.1158/1538-7445.Am2015-3179 |
0.37 |
|
| 2015 |
Rao CV, Sanghera S, Zhang Y, Biddick L, Reddy A, Lightfoot S, Mohammed A, Dai W, Yamada HY. Abstract 2881: Systemic Chromosome Instability (CIN) resulted in transcriptomic changes in metabolic and proliferation regulators in colonic mucosal tissue of Sgo1-/+ mice Cancer Research. 75: 2881-2881. DOI: 10.1158/1538-7445.Am2015-2881 |
0.479 |
|
| 2015 |
Mohammed A, Patlolla JMR, Zhang Y, Biddick L, Madka V, Li Q, Lightfoot S, Lubet R, Suen CS, Steele VE, Rao CV. Abstract 2820: Omeprazole alone, or in combination with Aspirin inhibits azoxymethane-induced colon adenoma progression to adenocarcinoma and carcinoma invasion in F344 rat model Cancer Research. 75: 2820-2820. DOI: 10.1158/1538-7445.Am2015-2820 |
0.532 |
|
| 2015 |
Mohammed A, Janakiram NB, Madka V, Brewer M, Ritchie RL, Lightfoot S, Kumar G, Sadeghi M, Patlolla JMR, Yamada H, Cruz-Monserrate Z, Houchen CW, Steele VE, Rao CV. Abstract 2819: Targeting inflammation and pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression Cancer Research. 75: 2819-2819. DOI: 10.1158/1538-7445.Am2015-2819 |
0.428 |
|
| 2015 |
Kumar G, Madka V, Mohammed A, Patolla JMr, Janakiram NB, Li Q, Zhang Y, Biddick L, Gillaspy A, Lightfoot S, Rao CV. Abstract 1905: Galectin-3 and -4 as signature markers of lung, colon, pancreatic and bladder tumor progression and chemopreventive interventions Cancer Research. 75: 1905-1905. DOI: 10.1158/1538-7445.Am2015-1905 |
0.359 |
|
| 2015 |
Patlolla JMR, Rao CV. Anti-inflammatory and Anti-cancer Properties of β-Escin, a Triterpene Saponin Current Pharmacology Reports. 1: 170-178. DOI: 10.1007/S40495-015-0019-9 |
0.363 |
|
| 2014 |
Mohammed A, Janakiram NB, Madka V, Ritchie RL, Brewer M, Biddick L, Patlolla JM, Sadeghi M, Lightfoot S, Steele VE, Rao CV. Eflornithine (DFMO) prevents progression of pancreatic cancer by modulating ornithine decarboxylase signaling. Cancer Prevention Research (Philadelphia, Pa.). 7: 1198-209. PMID 25248858 DOI: 10.1158/1940-6207.Capr-14-0176 |
0.533 |
|
| 2014 |
Pathuri G, Madka V, Hedrick AF, Lightfoot SA, Awasthi V, Cowley BD, Rao CV, Gali H. Evaluation of (99m)Tc-probestin SPECT as a novel technique for noninvasive imaging of kidney aminopeptidase N expression. Molecular Pharmaceutics. 11: 2948-53. PMID 24988047 DOI: 10.1021/Mp5002872 |
0.315 |
|
| 2014 |
Janakiram NB, Rao CV. The role of inflammation in colon cancer. Advances in Experimental Medicine and Biology. 816: 25-52. PMID 24818718 DOI: 10.1007/978-3-0348-0837-8_2 |
0.437 |
|
| 2014 |
Janakiram NB, Mohammed A, Bryant T, Brewer M, Biddick L, Lightfoot S, Lang ML, Rao CV. Adoptive transfer of regulatory T cells promotes intestinal tumorigenesis and is associated with decreased NK cells and IL-22 binding protein. Molecular Carcinogenesis. PMID 24797894 DOI: 10.1002/Mc.22168 |
0.392 |
|
| 2014 |
Madka V, Mohammed A, Li Q, Zhang Y, Patlolla JM, Biddick L, Lightfoot S, Wu XR, Steele V, Kopelovich L, Rao CV. Chemoprevention of urothelial cell carcinoma growth and invasion by the dual COX-LOX inhibitor licofelone in UPII-SV40T transgenic mice. Cancer Prevention Research (Philadelphia, Pa.). 7: 708-16. PMID 24795386 DOI: 10.1158/1940-6207.Capr-14-0087 |
0.495 |
|
| 2014 |
Pathuri G, Li Q, Mohammed A, Gali H, Pento JT, Rao CV. Synthesis and in vivo evaluation of N-ethylamino-2-oxo-1,2-dihydro-quinoline-3-carboxamide for inhibition of intestinal tumorigenesis in APC(Min/+) mice. Bioorganic & Medicinal Chemistry Letters. 24: 1380-2. PMID 24507628 DOI: 10.1016/J.Bmcl.2014.01.042 |
0.427 |
|
| 2014 |
Janakiram NB, Mohammed A, Brewer M, Bryant T, Biddick L, Lightfoot S, Pathuri G, Gali H, Rao CV. Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells. Cancer Prevention Research (Philadelphia, Pa.). 7: 300-9. PMID 24431404 DOI: 10.1158/1940-6207.Capr-13-0345 |
0.502 |
|
| 2014 |
Ravillah D, Mohammed A, Qian L, Brewer M, Zhang Y, Biddick L, Steele VE, Rao CV. Chemopreventive effects of an HDAC2-selective inhibitor on rat colon carcinogenesis and APCmin/+ mouse intestinal tumorigenesis. The Journal of Pharmacology and Experimental Therapeutics. 348: 59-68. PMID 24218540 DOI: 10.1124/Jpet.113.208645 |
0.809 |
|
| 2014 |
Rao CV, Sanghera S, Zhang Y, Biddick L, Lightfoot S, Dai W, Yamada HY. Abstract 93: Antagonizing pathways leading to differential dynamics in colonic carcinogenesis in azoxymethane (AOM)-treated Sgo1 (Shugoshin1)-haploinsufficient chromosome instability (CIN) model mice Cancer Research. 74: 93-93. DOI: 10.1158/1538-7445.Am2014-93 |
0.527 |
|
| 2014 |
Mohammed A, Janakiram NB, Ritchie RL, Biddick L, Brewer M, Lightfoot S, Steele VE, Rao CV. Abstract 2969: Combinational Targeting of EGFR and ODC pathways by Gefitinib and DFMO lead to complete blockade of PanIN progression to pancreatic ductal adenocarcinoma Cancer Research. 74: 2969-2969. DOI: 10.1158/1538-7445.Am2014-2969 |
0.524 |
|
| 2014 |
Janakiram NB, Mohammed A, Brewer M, Collin PD, Steele VE, Rao CV. Abstract 2145: Chemopreventive and immune-modulatory effects of the Cucumaria frondosa extract, Frondanol A5 in the APCMin/+ mice intestinal tumorigenesis Cancer Research. 74: 2145-2145. DOI: 10.1158/1538-7445.Am2014-2145 |
0.458 |
|
| 2014 |
Patlolla JMR, Kopelovich L, Qian L, Biddick L, Zhang Y, Sadeghi MK, Desai D, Amin S, Lightfoot S, Steele VE, Rao CV. Abstract 2135: Chemoprevention of tobacco carcinogen-induced lung cancer by DFMO and Licofelone administered individually or in combination in female A/J mice Cancer Research. 74: 2135-2135. DOI: 10.1158/1538-7445.Am2014-2135 |
0.5 |
|
| 2014 |
Vitale-Cross LA, Martin D, Rao CV, Kopelovich L, Gutkind JS. Abstract 1260: CP-31398 prevents the progression of oral squamous cell carcinomas from carcinogen-induced premalignant lesions Cancer Research. 74: 1260-1260. DOI: 10.1158/1538-7445.Am2014-1260 |
0.463 |
|
| 2013 |
Mohammed A, Janakiram NB, Brewer M, Ritchie RL, Marya A, Lightfoot S, Steele VE, Rao CV. Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling. Translational Oncology. 6: 649-59. PMID 24466367 DOI: 10.1593/Tlo.13556 |
0.482 |
|
| 2013 |
Janakiram NB, Mohammed A, Zhang Y, Brewer M, Bryant T, Lightfoot S, Steele VE, Rao CV. Chemopreventive efficacy of raloxifene, bexarotene, and their combination on the progression of chemically induced colon adenomas to adenocarcinomas in rats. Cancer Prevention Research (Philadelphia, Pa.). 6: 1251-61. PMID 24080207 DOI: 10.1158/1940-6207.Capr-13-0249 |
0.466 |
|
| 2013 |
Sureban SM, May R, Qu D, Weygant N, Chandrakesan P, Ali N, Lightfoot SA, Pantazis P, Rao CV, Postier RG, Houchen CW. DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer. Plos One. 8: e73940. PMID 24040120 DOI: 10.1371/Journal.Pone.0073940 |
0.366 |
|
| 2013 |
Rao CV, Patlolla JM, Qian L, Zhang Y, Brewer M, Mohammed A, Desai D, Amin S, Lightfoot S, Kopelovich L. Chemopreventive effects of the p53-modulating agents CP-31398 and Prima-1 in tobacco carcinogen-induced lung tumorigenesis in A/J mice. Neoplasia (New York, N.Y.). 15: 1018-27. PMID 24027427 DOI: 10.1593/Neo.131256 |
0.453 |
|
| 2013 |
Patlolla JM, Qian L, Biddick L, Zhang Y, Desai D, Amin S, Lightfoot S, Rao CV. β-Escin inhibits NNK-induced lung adenocarcinoma and ALDH1A1 and RhoA/Rock expression in A/J mice and growth of H460 human lung cancer cells. Cancer Prevention Research (Philadelphia, Pa.). 6: 1140-9. PMID 23963803 DOI: 10.1158/1940-6207.Capr-13-0216 |
0.464 |
|
| 2013 |
Madka V, Zhang Y, Li Q, Mohammed A, Sindhwani P, Lightfoot S, Wu XR, Kopelovich L, Rao CV. p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice. Neoplasia (New York, N.Y.). 15: 966-74. PMID 23908596 DOI: 10.1593/Neo.13704 |
0.481 |
|
| 2013 |
Benbrook DM, Guruswamy S, Wang Y, Sun Z, Mohammed A, Zhang Y, Li Q, Rao CV. Chemoprevention of colon and small intestinal tumorigenesis in APC(min/+) mice by SHetA2 (NSC721689) without toxicity. Cancer Prevention Research (Philadelphia, Pa.). 6: 908-16. PMID 23852423 DOI: 10.1158/1940-6207.Capr-13-0171 |
0.456 |
|
| 2013 |
Rao CV. Benzyl isothiocyanate: double trouble for breast cancer cells. Cancer Prevention Research (Philadelphia, Pa.). 6: 760-3. PMID 23842793 DOI: 10.1158/1940-6207.Capr-13-0242 |
0.455 |
|
| 2013 |
Rao CV, Yamada HY. Genomic instability and colon carcinogenesis: from the perspective of genes. Frontiers in Oncology. 3: 130. PMID 23734346 DOI: 10.3389/Fonc.2013.00130 |
0.386 |
|
| 2013 |
Hocker JR, Mohammed A, Aston CE, Brewer M, Lightfoot SA, Rao CV, Hanas JS. Mass profiling of serum to distinguish mice with pancreatic cancer induced by a transgenic Kras mutation. International Journal of Cancer. Journal International Du Cancer. 133: 2662-71. PMID 23712558 DOI: 10.1002/Ijc.28285 |
0.384 |
|
| 2013 |
Janakiram NB, Mohammed A, Ravillah D, Choi CI, Zhang Y, Desai D, Amin S, Rao CV. Chemopreventive effects of PBI-Se, a selenium-containing analog of PBIT, on AOM-induced aberrant crypt foci in F344 rats. Oncology Reports. 30: 952-60. PMID 23708609 DOI: 10.3892/Or.2013.2483 |
0.8 |
|
| 2013 |
Rao CV, Patlolla JM, Cooma I, Kawamori T, Steele VE. Prevention of familial adenomatous polyp development in APC min mice and azoxymethane-induced colon carcinogenesis in F344 Rats by ω-3 fatty acid rich perilla oil. Nutrition and Cancer. 65: 54-60. PMID 23682783 DOI: 10.1080/01635581.2013.785009 |
0.365 |
|
| 2013 |
Agarwal R, Kale RK, Rao CV, Singh RP. Introduction to Special Issue on Molecular Basis for Cancer Prevention with Bioactive Food Components in Nutrition and Cancer--an International Journal. Nutrition and Cancer. 65: 1-2. PMID 23682777 DOI: 10.1080/01635581.2013.785012 |
0.452 |
|
| 2013 |
Mohammed A, Janakiram NB, Brewer M, Vedala K, Steele VE, Rao CV. Multitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesis. Neoplasia (New York, N.Y.). 15: 481-90. PMID 23633920 DOI: 10.1593/Neo.13282 |
0.538 |
|
| 2013 |
Madka V, Rao CV. Anti-inflammatory phytochemicals for chemoprevention of colon cancer. Current Cancer Drug Targets. 13: 542-57. PMID 23597198 DOI: 10.2174/15680096113139990036 |
0.482 |
|
| 2013 |
Mohammed A, Janakiram NB, Brewer M, Ritchie RL, Lightfoot S, Steele VE, Rao CV. Abstract PR02: Combinational targeting of 5-LOX/COX and PI3K/AKT signaling to prevent progression of PanINs to pancreatic ductal adenocarcinoma in p48Cre/+.LSL-KrasG12D/+ mice Cancer Prevention Research. 6. DOI: 10.1158/1940-6215.Prev-13-Pr02 |
0.444 |
|
| 2013 |
Janakiram NB, Mohammed A, Zhang Y, Brewer M, Bryant T, Biddick L, Lightfoot S, Steele VE, Rao CV. Abstract A15: Chemopreventive efficacy of Phospho-Ibuprofen, Rosuvastatin and their combination on AOM-induced colon adenocarcinoma formation in F344 rats Cancer Prevention Research. 6. DOI: 10.1158/1940-6215.Prev-13-A15 |
0.559 |
|
| 2013 |
Madka V, Zhang Y, Brewer M, Qian L, Mohammed A, Lightfoot S, Steele VE, Kopelovich L, Rao CV. Abstract A14: Chemopreventive efficacy of bisphosphonates, Zometa and Fosamax, alone or in combination with metformin in AOM-induced rat colon cancer model Cancer Prevention Research. 6. DOI: 10.1158/1940-6215.Prev-13-A14 |
0.546 |
|
| 2013 |
Patlolla JMR, Kopelovich L, Qian L, Biddick L, Zhang Y, Desai D, Amin S, Lightfoot S, Rao CV. Abstract LB-182: Licofelone inhibits NNK-induced lung adenocarcinoma formation in A/J mice by suppressing COX/LOX and inhibits human lung cancer cell growth by p21 up-regulation. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-182 |
0.476 |
|
| 2013 |
Madka V, Zhang Y, Li Q, Mohammed A, Lightfoot S, Xue WR, Kopelovich L, Rao CV. Abstract 3690: p53 stabilizing agent CP-31398 prevents urinary bladder tumor growth and invasion in transgenic UPII-SV40T mice. Cancer Research. 73: 3690-3690. DOI: 10.1158/1538-7445.Am2013-3690 |
0.503 |
|
| 2013 |
Mohammed A, Brewer M, Ritchie RL, Marya A, Lightfoot S, Janakiram NB, Steele VE, Rao CV. Abstract 2268: Metformin prevents progression of pancreatic intraepithelial neoplasia to ductal adenocarcinoma by targeting cancer stem cells and mTOR signaling. Cancer Research. 73: 2268-2268. DOI: 10.1158/1538-7445.Am2013-2268 |
0.401 |
|
| 2013 |
Janakiram NB, Mohammed A, Bryant T, Zhang Y, Brewer M, Duff A, Biddick L, Lightfoot S, Steele V, Rao CV. Abstract 186: Clinically relevant low dose combination of rosuvastatin and difluoromethylornithine provides effective chemopreventive efficacy against AOM-induced colon cancers in F344 rats . Cancer Research. 73: 186-186. DOI: 10.1158/1538-7445.Am2013-186 |
0.505 |
|
| 2013 |
Yamada HY, Zhang Y, Dai W, Rao CV. Abstract 1752: Consequences of high Chromosome Instability (CIN) in SGO1(Shugoshin1) CIN model mice. Cancer Research. 73: 1752-1752. DOI: 10.1158/1538-7445.Am2013-1752 |
0.414 |
|
| 2012 |
Janakiram NB, Rao CV. Chemoprevention of Colon Cancer by iNOS-Selective Inhibitors. Forum On Immunopathological Diseases and Therapeutics. 3: 155-167. PMID 23678395 DOI: 10.1615/Forumimmundisther.2012006186 |
0.475 |
|
| 2012 |
Mohammed A, Janakiram NB, Brewer M, Duff A, Lightfoot S, Brush RS, Anderson RE, Rao CV. Endogenous n-3 polyunsaturated fatty acids delay progression of pancreatic ductal adenocarcinoma in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+) mice. Neoplasia (New York, N.Y.). 14: 1249-59. PMID 23308056 DOI: 10.1593/Neo.121508 |
0.425 |
|
| 2012 |
Rao CV, Janakiram NB, Mohammed A. Lipoxygenase and Cyclooxygenase Pathways and Colorectal Cancer Prevention. Current Colorectal Cancer Reports. 8: 316-324. PMID 23293573 DOI: 10.1007/S11888-012-0146-1 |
0.449 |
|
| 2012 |
Janakiram NB, Rao CV. iNOS-selective inhibitors for cancer prevention: promise and progress. Future Medicinal Chemistry. 4: 2193-204. PMID 23190107 DOI: 10.4155/Fmc.12.168 |
0.456 |
|
| 2012 |
Rao CV, Kurkjian CD, Yamada HY. Mitosis-targeting natural products for cancer prevention and therapy. Current Drug Targets. 13: 1820-30. PMID 23140292 DOI: 10.2174/138945012804545533 |
0.413 |
|
| 2012 |
Rao CV, Mohammed A, Janakiram NB, Li Q, Ritchie RL, Lightfoot S, Vibhudutta A, Steele VE. Inhibition of pancreatic intraepithelial neoplasia progression to carcinoma by nitric oxide-releasing aspirin in p48(Cre/+)-LSL-Kras(G12D/+) mice. Neoplasia (New York, N.Y.). 14: 778-87. PMID 23019409 DOI: 10.1593/Neo.121026 |
0.488 |
|
| 2012 |
Mohammed A, Janakiram NB, Lightfoot S, Gali H, Vibhudutta A, Rao CV. Early detection and prevention of pancreatic cancer: use of genetically engineered mouse models and advanced imaging technologies. Current Medicinal Chemistry. 19: 3701-13. PMID 22680929 DOI: 10.2174/092986712801661095 |
0.361 |
|
| 2012 |
Janakiram NB, Mohammed A, Bronze MS, Rao CV. Prophylactic vaccine approach for colon and pancreatic cancers: present and future. Current Medicinal Chemistry. 19: 3664-3678. PMID 22680926 DOI: 10.2174/092986712801661022 |
0.39 |
|
| 2012 |
Doppalapudi RS, Riccio ES, Davis Z, Menda S, Wang A, Du N, Green C, Kopelovich L, Rao CV, Benbrook DM, Kapetanovic IM. Genotoxicity of the cancer chemopreventive drug candidates CP-31398, SHetA2, and phospho-ibuprofen. Mutation Research. 746: 78-88. PMID 22498038 DOI: 10.1016/J.Mrgentox.2012.03.009 |
0.315 |
|
| 2012 |
Janakiram NB, Mohammed A, Qian L, Choi CI, Steele VE, Rao CV. Chemopreventive effects of RXR-selective rexinoid bexarotene on intestinal neoplasia of Apc(Min/+) mice. Neoplasia (New York, N.Y.). 14: 159-68. PMID 22431924 DOI: 10.1593/Neo.111440 |
0.532 |
|
| 2012 |
Kapetanovic IM, Muzzio M, McCormick DL, Thompson TN, Johnson WD, Horn TL, Mohammed A, Rao CV, Kopelovich L. Pharmacokinetics and tissue and tumor exposure of CP-31398, a p53-stabilizing agent, in rats. Cancer Chemotherapy and Pharmacology. 69: 1301-6. PMID 22302406 DOI: 10.1007/S00280-011-1811-9 |
0.397 |
|
| 2012 |
Mohammed A, Qian L, Janakiram NB, Lightfoot S, Steele VE, Rao CV. Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice. International Journal of Cancer. Journal International Du Cancer. 131: 1951-62. PMID 22287227 DOI: 10.1002/Ijc.27456 |
0.488 |
|
| 2012 |
Yamada HY, Yao Y, Wang X, Zhang Y, Huang Y, Dai W, Rao CV. Haploinsufficiency of SGO1 results in deregulated centrosome dynamics, enhanced chromosomal instability and colon tumorigenesis. Cell Cycle (Georgetown, Tex.). 11: 479-88. PMID 22262168 DOI: 10.4161/Cc.11.3.18994 |
0.392 |
|
| 2012 |
Patlolla JM, Zhang Y, Li Q, Steele VE, Rao CV. Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation in rats. International Journal of Oncology. 40: 170-5. PMID 21956158 DOI: 10.3892/Ijo.2011.1214 |
0.547 |
|
| 2012 |
Patlolla JM, Rao CV. Triterpenoids for cancer prevention and treatment: current status and future prospects. Current Pharmaceutical Biotechnology. 13: 147-55. PMID 21466427 DOI: 10.2174/138920112798868719 |
0.477 |
|
| 2012 |
Rao CV. Abstract ED02-03: Animal models for human pancreatic cancer prevention Cancer Prevention Research. 5. DOI: 10.1158/1940-6207.Prev-12-Ed02-03 |
0.448 |
|
| 2012 |
Mohammed A, Janakiram NB, Brewer M, Ritchie RL, Marya A, Lightfoot S, Steele VE, Rao CV. Abstract B115: Eflornithine (DFMO) Prevents Progression of Pancreatic Intraepithelial Neoplasia to Ductal Adenocarcinoma in LSL-KrasG12D/+ Mice Cancer Prevention Research. 5. DOI: 10.1158/1940-6207.Prev-12-B115 |
0.422 |
|
| 2012 |
Janakiram NB, Mohammed A, Brewer MF, Gillaspy A, Lightfoot S, Steele VE, Rao CV. Abstract B114: Next generation whole genome transcriptome SOLiD sequencing analysis of pancreatic ductal adenocarcinoma in LSL-KrasG12D/+ mice Cancer Prevention Research. 5. DOI: 10.1158/1940-6207.Prev-12-B114 |
0.437 |
|
| 2012 |
Patlolla JMR, Kopelovich L, Qian L, Biddick L, Zhang Y, Desai D, Amin S, Lightfoot S, Rao CV. Abstract B111: Early and Delayed Rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice Cancer Prevention Research. 5. DOI: 10.1158/1940-6207.Prev-12-B111 |
0.46 |
|
| 2012 |
Madka V, Mohammed A, Biddick L, Zhang Y, Newman RA, Aggarwal BB, Rao CV. Abstract LB-177: A supercritical turmeric extract prevents small intestinal and colonic tumors in the APCMin/+ mice by suppressing proliferation and cancer stem cell markers Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-177 |
0.481 |
|
| 2012 |
Rao CV, Patlolla JMR, Qian L, Zhang Y, Brewer M, Mohammed A, Desai D, Amin S, Lightfoot S, Kopelovich L. Abstract LB-176: Chemoprevention of NNK-induced lung adenoma and adenocarcinoma in A/J mice by p53 modulating agents, CP-31398 and Prima-1 Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-176 |
0.467 |
|
| 2012 |
Patlolla JMR, Qian L, Barton L, Zhang Y, Desai D, Amin S, Lightfoot S, Rao C. Abstract LB-175: β-Escin inhibits NNK-induced lung adenocarcinoma formation in A/J mice by suppressing ALDH1A1 positive cells; and RhoA/Rock induced invasion of human lung cancer cell growth. Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-175 |
0.388 |
|
| 2012 |
Janakiram NB, Mohammed A, Zhang Y, Brewer M, Lightfoot S, Steele VE, Rao CV. Abstract 1633: Chemopreventive efficacy of raloxifene, bexarotene and their combination on the progression of AOM-induced colon adenomas to adenocarcinomas in F344 rats Cancer Research. 72: 1633-1633. DOI: 10.1158/1538-7445.Am2012-1633 |
0.543 |
|
| 2012 |
Mohammed A, Janakiram NB, Brewer M, Biddick L, Lightfoot S, Steele VE, Rao CV. Abstract 1005: Targeting COX-LOX and EGFR pathways simultaneously by licofelone and gefitinib lead to complete blockade of progression of PanINs to pancreatic ductal adenocarcinoma Cancer Research. 72: 1005-1005. DOI: 10.1158/1538-7445.Am2012-1005 |
0.53 |
|
| 2011 |
Madka V, Rao CV. Cancer stem cell markers as potential targets for epithelial cancers. Indian Journal of Experimental Biology. 49: 826-35. PMID 22126013 |
0.345 |
|
| 2011 |
Janakiram NB, Mohammed A, Rao CV. Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer. Cancer Metastasis Reviews. 30: 507-23. PMID 22015691 DOI: 10.1007/S10555-011-9311-2 |
0.456 |
|
| 2011 |
Mohammed A, Janakiram NB, Li Q, Choi CI, Zhang Y, Steele VE, Rao CV. Chemoprevention of colon and small intestinal tumorigenesis in APC(Min/+) mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention. Cancer Prevention Research (Philadelphia, Pa.). 4: 2015-26. PMID 21885812 DOI: 10.1158/1940-6207.Capr-11-0233 |
0.549 |
|
| 2011 |
Suh N, Reddy BS, DeCastro A, Paul S, Lee HJ, Smolarek AK, So JY, Simi B, Wang CX, Janakiram NB, Steele V, Rao CV. Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats. Cancer Prevention Research (Philadelphia, Pa.). 4: 1895-902. PMID 21764859 DOI: 10.1158/1940-6207.Capr-11-0222 |
0.524 |
|
| 2011 |
Zheng X, Cui XX, Gao Z, Zhao Y, Shi Y, Huang MT, Liu Y, Wagner GC, Lin Y, Shih WJ, Rao CV, Yang CS, Conney AH. Inhibitory effect of dietary atorvastatin and celecoxib together with voluntary running wheel exercise on the progression of androgen-dependent LNCaP prostate tumors to androgen independence. Experimental and Therapeutic Medicine. 2: 221-228. PMID 21660218 DOI: 10.3892/Etm.2011.203 |
0.408 |
|
| 2011 |
Joyner PM, Waters AL, Williams RB, Powell DR, Janakiram NB, Rao CV, Cichewicz RH. Briarane diterpenes diminish COX-2 expression in human colon adenocarcinoma cells. Journal of Natural Products. 74: 857-61. PMID 21438584 DOI: 10.1021/Np100775A |
0.383 |
|
| 2011 |
Sureban SM, May R, Lightfoot SA, Hoskins AB, Lerner M, Brackett DJ, Postier RG, Ramanujam R, Mohammed A, Rao CV, Wyche JH, Anant S, Houchen CW. DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism. Cancer Research. 71: 2328-38. PMID 21285251 DOI: 10.1158/0008-5472.Can-10-2738 |
0.417 |
|
| 2011 |
Rao CV, Janakiram NB, Mohammed A, Madka V, Qian L, Brewer M, Duff A, Zhang Y, Steele VE. Abstract B42: Lack of chemopreventive effects of metformin in azoxymethane-induced rat colon carcinogenesis Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-B42 |
0.536 |
|
| 2011 |
Mohammed A, Janakiram NB, Brewer M, Duff A, Lightfoot S, Brush RS, Anderson RE, Rao CV. Abstract A111: Endogenous conversion of n-6 PUFAs to n-3 PUFAs prevents progression of K-Ras activated pancreatic lesion development to pancreatic ductal carcinoma in Fat-1 transgenic mice Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-A111 |
0.458 |
|
| 2011 |
Suh N, Reddy BS, Paul S, DeCastro A, Lee HJ, Smolarek AK, So JY, Simi B, Wang CX, Janakiram NB, Steele VE, Rao CV. Abstract 833: Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/beta-catenin/cyclin D1 signaling pathway in rats Cancer Research. 71: 833-833. DOI: 10.1158/1538-7445.Am2011-833 |
0.535 |
|
| 2011 |
Janakiram NB, Mohammed A, Qian L, Venkateshwar M, Reddy MP, Steele VE, Rao CV. Abstract 831: Chemopreventive effects of selective estrogen receptor modulator (SERM) raloxifene on intestinal neoplasia of APCMin/+ mice Cancer Research. 71: 831-831. DOI: 10.1158/1538-7445.Am2011-831 |
0.523 |
|
| 2011 |
Patlolla JMR, Lubet R, Ely M, Zhang Y, Janakiram NB, Madka V, Mohammed A, Steele VE, Rao CV. Abstract 808: Chemoprevention of colon cancer by DFMO, sulindac and NO-sulindac administered individually or in combinations in male F344 rats Cancer Research. 71: 808-808. DOI: 10.1158/1538-7445.Am2011-808 |
0.553 |
|
| 2011 |
Yamada HY, Zhang Y, Dai W, Rao CV. Abstract 2983: Sgo1 haploinsufficiency contributes to enhanced colon carcinogenesis in mice and yet associated with high colonic epithelial apoptosis Cancer Research. 71: 2983-2983. DOI: 10.1158/1538-7445.Am2011-2983 |
0.476 |
|
| 2011 |
Mohammed A, Janakiram NB, Ely M, Lightfoot S, Steele VE, Rao CV. Abstract 2839: Licofelone, a novel dual COX-LOX inhibitor prevents progression of PanIN lesions to pancreatic carcinoma by targeting miRNAs and cancer stem cells in p48Cre/+-LSL-KrasG12D/+ transgenic mice Cancer Research. 71: 2839-2839. DOI: 10.1158/1538-7445.Am2011-2839 |
0.522 |
|
| 2011 |
Mustafi R, Dougherty U, Toth PT, Joseph LJ, Hart J, Rao CV, Fichera A, Bissonnette M. Fish Oils Inhibit EGFR Signals in Normal Mouse Colon and Suppress up-Regulated EGFR Signals in AOM Rat Colon Cancers. In Vitro Dissection of Mechanism Involving Lipid Rafts Gastroenterology. 140. DOI: 10.1016/S0016-5085(11)60331-4 |
0.391 |
|
| 2010 |
Mohammed A, Janakiram NB, Li Q, Madka V, Ely M, Lightfoot S, Crawford H, Steele VE, Rao CV. The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-KrasG12D/+ transgenic mouse model. Cancer Prevention Research (Philadelphia, Pa.). 3: 1417-26. PMID 21084261 DOI: 10.1158/1940-6207.Capr-10-0038 |
0.479 |
|
| 2010 |
May R, Sureban SM, Lightfoot SA, Hoskins AB, Brackett DJ, Postier RG, Ramanujam R, Rao CV, Wyche JH, Anant S, Houchen CW. Identification of a novel putative pancreatic stem/progenitor cell marker DCAMKL-1 in normal mouse pancreas. American Journal of Physiology. Gastrointestinal and Liver Physiology. 299: G303-10. PMID 20522640 DOI: 10.1152/Ajpgi.00146.2010 |
0.355 |
|
| 2010 |
Janakiram NB, Mohammed A, Zhang Y, Choi CI, Woodward C, Collin P, Steele VE, Rao CV. Chemopreventive effects of Frondanol A5, a Cucumaria frondosa extract, against rat colon carcinogenesis and inhibition of human colon cancer cell growth. Cancer Prevention Research (Philadelphia, Pa.). 3: 82-91. PMID 20051375 DOI: 10.1158/1940-6207.Capr-09-0112 |
0.452 |
|
| 2010 |
Mohammed A, Janakiram N, Ely M, Vernon SE, Rao CV. Abstract B55: Multitargeted low-dose combination chemoprevention: A novel, ideal, and promising approach to combat colon carcinogenesis Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-10-B55 |
0.572 |
|
| 2010 |
Rao CV, Guruswamy S, Patlolla JMR, Janakiram N, Malisetty VS. Abstract A53: Chemoprevention of colon cancer by PBIT, an iNOS‐selective inhibitor, administered alone or in combination with low‐doses of celecoxib, a COX‐2 selective inhibitor Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-A53 |
0.547 |
|
| 2010 |
Janakiram NB, Mohammed A, Ravillah D, Choi CI, Zhang Y, Desai D, Amin S, Rao CV. Abstract A35: Chemoprevention of colon carcinogenesis in F344 rats by Se,Se′‐1,4‐phenylenebis(1,2‐ethanediyl)bis‐isoselenourea (PBISe) a novel analog of PBIT, an iNOS inhibitor Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-A35 |
0.805 |
|
| 2010 |
Mohammed A, Qian L, Lightfoot S, Vernon SE, Rao CV. Abstract A145: Atorvastatin (Lipitor) delays progression of PanINs to pancreatic carcinoma through AKT pathway in a conditional LSL‐K‐rasG12D transgenic mice Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-A145 |
0.471 |
|
| 2010 |
Patlolla JMR, Zhang Y, Qian L, Steele VE, Rao CV. Abstract A141: Chemopreventive properties of omeprazole against azoxymethane‐induced colonic aberrant crypt foci formation in fats Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-A141 |
0.527 |
|
| 2010 |
Guruswamy S, Benbrook D, Zhang Y, Qian L, Mohammed A, Rao CV. Abstract A140: Chemoprevention of familial adenomatous polyposis by a flexible‐heteroarotinoid (Flex‐Het), SHetA2, in APCMin mice Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-A140 |
0.5 |
|
| 2010 |
Narayanan NK, Horton L, Lasano S, Bosland MC, Rao CV, Narayanan BA. Abstract LB-422: A novel mechanism for the anti-cancer effects of licofelone against testosterone and estradiol-17ß-induced prostate carcinogenesis: Selective modulation of the cross-talk between estrogen receptor and NF-κB Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-422 |
0.343 |
|
| 2010 |
Janakiram NB, Swamy MV, Patlolla JM, Guruswamy S, Rao CV. Abstract 954: A selective iNOS inhibitor N6-iminoethyl-lysine tetrazoleamide (NILT), suppress invasive colonic cancers and improves preventive efficacy of low-dose COX-2 inhibitor, celecoxib in F344 rats Cancer Research. 70: 954-954. DOI: 10.1158/1538-7445.Am10-954 |
0.56 |
|
| 2010 |
Mohammed A, Janakiram NB, Qian L, Madka V, Ely M, Lightfoot S, Steele VE, Rao CV. Abstract 2927: Gefitinib, an EGFR inhibitor, prevents progression of PanINs to pancreatic carcinoma in a preclinical conditionalLSL-K-rasG12Dtransgenic mice model Cancer Research. 70: 2927-2927. DOI: 10.1158/1538-7445.Am10-2927 |
0.504 |
|
| 2009 |
Steele VE, Rao CV, Zhang Y, Patlolla J, Boring D, Kopelovich L, Juliana MM, Grubbs CJ, Lubet RA. Chemopreventive efficacy of naproxen and nitric oxide-naproxen in rodent models of colon, urinary bladder, and mammary cancers. Cancer Prevention Research (Philadelphia, Pa.). 2: 951-6. PMID 19892664 DOI: 10.1158/1940-6207.Capr-09-0080 |
0.518 |
|
| 2009 |
Rao CV, Steele VE, Swamy MV, Patlolla JM, Guruswamy S, Kopelovich L. Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats. Cancer Research. 69: 8175-82. PMID 19826045 DOI: 10.1158/0008-5472.Can-09-1377 |
0.547 |
|
| 2009 |
Yamada HY, Rao CV. BRD8 is a potential chemosensitizing target for spindle poisons in colorectal cancer therapy. International Journal of Oncology. 35: 1101-9. PMID 19787264 DOI: 10.3892/Ijo_00000425 |
0.477 |
|
| 2009 |
Guruswamy S, Rao CV. Synergistic effects of lovastatin and celecoxib on caveolin-1 and its down-stream signaling molecules: Implications for colon cancer prevention. International Journal of Oncology. 35: 1037-43. PMID 19787257 DOI: 10.3892/Ijo_00000418 |
0.454 |
|
| 2009 |
Janakiram NB, Rao CV. Role of lipoxins and resolvins as anti-inflammatory and proresolving mediators in colon cancer. Current Molecular Medicine. 9: 565-79. PMID 19601807 DOI: 10.2174/156652409788488748 |
0.319 |
|
| 2009 |
Rao CV, Yamada HY, Yao Y, Dai W. Enhanced genomic instabilities caused by deregulated microtubule dynamics and chromosome segregation: a perspective from genetic studies in mice. Carcinogenesis. 30: 1469-74. PMID 19372138 DOI: 10.1093/Carcin/Bgp081 |
0.325 |
|
| 2009 |
Janakiram NB, Steele VE, Rao CV. Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats. Cancer Prevention Research (Philadelphia, Pa.). 2: 52-9. PMID 19139018 DOI: 10.1158/1940-6207.Capr-08-0140 |
0.488 |
|
| 2009 |
Mandal MN, Patlolla JM, Zheng L, Agbaga MP, Tran JT, Wicker L, Kasus-Jacobi A, Elliott MH, Rao CV, Anderson RE. Curcumin protects retinal cells from light-and oxidant stress-induced cell death. Free Radical Biology & Medicine. 46: 672-9. PMID 19121385 DOI: 10.1016/J.Freeradbiomed.2008.12.006 |
0.358 |
|
| 2009 |
Grubbs CJ, Steele V, Boring D, Lubet R, Rao C, Zhang Y, Patlolla J. Abstract A94: Preventive effects of naproxen and NO‐naproxen in carcinogen induced models of urinary bladder, colon, and mammary cancers Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-A94 |
0.515 |
|
| 2009 |
May R, Sureban SM, Lightfoot SA, Brackett DJ, Postier RG, Ramanujam RP, Wyche JH, Han Z, Rao CV, Anant S, Houchen CW. 60 Identification of a Novel Pancreatic Stem Cell Marker DCAMKL-1 in Mouse Pancreas and in Pancreatic Cancer Gastroenterology. 136: A-10. DOI: 10.1016/S0016-5085(09)60050-0 |
0.374 |
|
| 2008 |
Guruswamy S, Rao CV. Multi-Target Approaches in Colon Cancer Chemoprevention Based on Systems Biology of Tumor Cell-Signaling. Gene Regulation and Systems Biology. 2: 163-176. PMID 19763245 DOI: 10.4137/Grsb.S486 |
0.468 |
|
| 2008 |
Swamy MV, Citineni B, Patlolla JM, Mohammed A, Zhang Y, Rao CV. Prevention and treatment of pancreatic cancer by curcumin in combination with omega-3 fatty acids. Nutrition and Cancer. 60: 81-9. PMID 19003584 DOI: 10.1080/01635580802416703 |
0.455 |
|
| 2008 |
Rigas B, Rao CV, Cooney R, Singh S. Food components, alternative medicine, and cancer: progress and promise. Nutrition and Cancer. 60: 1. PMID 19003574 DOI: 10.1080/01635580802393134 |
0.412 |
|
| 2008 |
Rao CV, Joseph S, Gao L, Patlolla JM, Choi CI, Kopelovich L, Steele VE, Rigas B. Pharmacokinetic and pharmacodynamic study of NO-donating aspirin in F344 rats. International Journal of Oncology. 33: 799-805. PMID 18813794 DOI: 10.3892/Ijo_00000067 |
0.37 |
|
| 2008 |
Rao CV, Swamy MV, Patlolla JM, Kopelovich L. Suppression of familial adenomatous polyposis by CP-31398, a TP53 modulator, in APCmin/+ mice. Cancer Research. 68: 7670-5. PMID 18794156 DOI: 10.1158/0008-5472.Can-08-1610 |
0.45 |
|
| 2008 |
Janakiram NB, Indranie C, Malisetty SV, Jagan P, Steele VE, Rao CV. Chemoprevention of colon carcinogenesis by oleanolic acid and its analog in male F344 rats and modulation of COX-2 and apoptosis in human colon HT-29 cancer cells. Pharmaceutical Research. 25: 2151-7. PMID 18408893 DOI: 10.1007/S11095-008-9582-7 |
0.419 |
|
| 2008 |
Janakiram NB, Cooma I, Mohammed A, Steele VE, Rao CV. Beta-ionone inhibits colonic aberrant crypt foci formation in rats, suppresses cell growth, and induces retinoid X receptor-alpha in human colon cancer cells. Molecular Cancer Therapeutics. 7: 181-90. PMID 18202021 DOI: 10.1158/1535-7163.Mct-07-0529 |
0.47 |
|
| 2008 |
Janakiram NB, Rao CV. Molecular markers and targets for colorectal cancer prevention. Acta Pharmacologica Sinica. 29: 1-20. PMID 18158862 DOI: 10.1111/J.1745-7254.2008.00742.X |
0.419 |
|
| 2008 |
Guruswamy S, Swamy MV, Choi CI, Steele VE, Rao CV. S-adenosyl L-methionine inhibits azoxymethane-induced colonic aberrant crypt foci in F344 rats and suppresses human colon cancer Caco-2 cell growth in 3D culture. International Journal of Cancer. Journal International Du Cancer. 122: 25-30. PMID 17724725 DOI: 10.1002/Ijc.23031 |
0.479 |
|
| 2007 |
Rao CV. Regulation of COX and LOX by curcumin. Advances in Experimental Medicine and Biology. 595: 213-26. PMID 17569213 DOI: 10.1007/978-0-387-46401-5_9 |
0.351 |
|
| 2007 |
Kurkjian C, Janakiram NB, Guruswamy S, Rao CV, Ozer H. The effects of licofelone, a dual lipoxygenase and cyclooxygenase inhibitor, with and without rosiglitazone in human MCF-7 and MDA-MB-231 breast cancer cells Journal of Clinical Oncology. 25: 1537-1537. DOI: 10.1200/Jco.2007.25.18_Suppl.1537 |
0.39 |
|
| 2006 |
Swamy MV, Patlolla JM, Steele VE, Kopelovich L, Reddy BS, Rao CV. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice. Cancer Research. 66: 7370-7. PMID 16849589 DOI: 10.1158/0008-5472.Can-05-4619 |
0.501 |
|
| 2006 |
Rao CV, Reddy BS, Steele VE, Wang CX, Liu X, Ouyang N, Patlolla JM, Simi B, Kopelovich L, Rigas B. Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets. Molecular Cancer Therapeutics. 5: 1530-8. PMID 16818512 DOI: 10.1158/1535-7163.Mct-06-0061 |
0.544 |
|
| 2006 |
Patlolla JM, Raju J, Swamy MV, Rao CV. Beta-escin inhibits colonic aberrant crypt foci formation in rats and regulates the cell cycle growth by inducing p21(waf1/cip1) in colon cancer cells. Molecular Cancer Therapeutics. 5: 1459-66. PMID 16818504 DOI: 10.1158/1535-7163.Mct-05-0495 |
0.436 |
|
| 2006 |
Reddy BS, Wang CX, Kong AN, Khor TO, Zheng X, Steele VE, Kopelovich L, Rao CV. Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats. Cancer Research. 66: 4542-6. PMID 16618783 DOI: 10.1158/0008-5472.Can-05-4428 |
0.487 |
|
| 2006 |
El-Bayoumy K, Das A, Narayanan B, Narayanan N, Fiala ES, Desai D, Rao CV, Amin S, Sinha R. Molecular targets of the chemopreventive agent 1,4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer. Carcinogenesis. 27: 1369-76. PMID 16399772 DOI: 10.1093/Carcin/Bgi328 |
0.44 |
|
| 2005 |
Reddy BS, Rao CV. Chemoprophylaxis of colon cancer. Current Gastroenterology Reports. 7: 389-95. PMID 16168238 DOI: 10.1007/S11894-005-0009-X |
0.458 |
|
| 2005 |
Reddy BS, Patlolla JM, Simi B, Wang SH, Rao CV. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids. Cancer Research. 65: 8022-7. PMID 16140976 DOI: 10.1158/0008-5472.Can-05-0212 |
0.494 |
|
| 2005 |
Rao CV, Yang YM, Swamy MV, Liu T, Fang Y, Mahmood R, Jhanwar-Uniyal M, Dai W. Colonic tumorigenesis in BubR1+/-ApcMin/+ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability. Proceedings of the National Academy of Sciences of the United States of America. 102: 4365-70. PMID 15767571 DOI: 10.1073/Pnas.0407822102 |
0.406 |
|
| 2005 |
Raju J, Swamy MV, Cooma I, Patlolla JM, Pittman B, Reddy BS, Steele VE, Rao CV. Low doses of beta-carotene and lutein inhibit AOM-induced rat colonic ACF formation but high doses augment ACF incidence. International Journal of Cancer. Journal International Du Cancer. 113: 798-802. PMID 15499611 DOI: 10.1002/Ijc.20640 |
0.464 |
|
| 2004 |
Rao CV. Nitric oxide signaling in colon cancer chemoprevention. Mutation Research. 555: 107-19. PMID 15476855 DOI: 10.1016/J.Mrfmmm.2004.05.022 |
0.469 |
|
| 2004 |
Raju J, Patlolla JM, Swamy MV, Rao CV. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 1392-8. PMID 15298963 |
0.419 |
|
| 2004 |
Patlolla JM, Swamy MV, Raju J, Rao CV. Overexpression of caveolin-1 in experimental colon adenocarcinomas and human colon cancer cell lines. Oncology Reports. 11: 957-63. PMID 15069532 DOI: 10.3892/Or.11.5.957 |
0.399 |
|
| 2004 |
Swamy MV, Cooma I, Patlolla JM, Simi B, Reddy BS, Rao CV. Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: novel strategies for colon cancer prevention and treatment. Molecular Cancer Therapeutics. 3: 215-21. PMID 14985462 |
0.341 |
|
| 2004 |
Rao CV, Reddy BS. NSAIDs and chemoprevention. Current Cancer Drug Targets. 4: 29-42. PMID 14965265 DOI: 10.2174/1568009043481632 |
0.493 |
|
| 2004 |
Dai W, Wang Q, Liu T, Swamy M, Fang Y, Xie S, Mahmood R, Yang YM, Xu M, Rao CV. Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency. Cancer Research. 64: 440-5. PMID 14744753 DOI: 10.1158/0008-5472.Can-03-3119 |
0.418 |
|
| 2003 |
Rao CV. Do irradiated foods cause or promote colon cancer? Nutrition and Cancer. 46: 107-9. PMID 14690784 DOI: 10.1207/S15327914Nc4602_01 |
0.37 |
|
| 2002 |
Rao CV, Newmark HL, Reddy BS. Chemopreventive effect of farnesol and lanosterol on colon carcinogenesis. Cancer Detection and Prevention. 26: 419-25. PMID 12507226 |
0.341 |
|
| 2002 |
Reddy BS, Rao CV. Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors. Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society For Environmental Toxicology and Cancer. 21: 155-64. PMID 12086402 DOI: 10.1615/Jenvironpatholtoxicoloncol.V21.I2.90 |
0.487 |
|
| 2002 |
Swamy MV, Cooma I, Reddy BS, Rao CV. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens. International Journal of Oncology. 20: 753-9. PMID 11894121 DOI: 10.3892/Ijo.20.4.753 |
0.426 |
|
| 2002 |
El-Bayoumy K, Rose DP, Papanikolaou N, Leszczynska J, Swamy MV, Rao CV. Cyclooxygenase-2 expression influences the growth of human large and small cell lung carcinoma lines in athymic mice: impact of an organoselenium compound on growth regulation. International Journal of Oncology. 20: 557-561. PMID 11836568 DOI: 10.3892/Ijo.20.3.557 |
0.466 |
|
| 2002 |
Dai W, Liu T, Wang Q, Rao CV, Reddy BS. Down-regulation of PLK3 gene expression by types and amount of dietary fat in rat colon tumors. International Journal of Oncology. 20: 121-6. PMID 11743651 |
0.34 |
|
| 2002 |
Dai W, Liu T, Wang Q, Rao CV, Reddy BS. Down-regulation of PLK3 gene expression by types and amount of dietary fat in rat colon tumors. International Journal of Oncology. 20: 121-126. DOI: 10.3892/Ijo.20.1.121 |
0.446 |
|
| 2001 |
Hirose Y, Rao CV, Reddy BS. Modulation of inducible nitric oxide synthase expression in rat intestinal cells by colon tumor promoters. International Journal of Oncology. 18: 141-147. DOI: 10.3892/Ijo.18.1.141 |
0.372 |
|
| 2000 |
Chung F, Conaway CC, Rao CV, Reddy BS. Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis. 21: 2287-2291. PMID 11133820 DOI: 10.1093/Carcin/21.12.2287 |
0.521 |
|
| 2000 |
Reddy BS, Rao CV. Colon cancer. A role for cyclo-oxygenase-2-specific nonsteroidal anti-inflammatory drugs Drugs and Aging. 16: 329-334. PMID 10917070 DOI: 10.2165/00002512-200016050-00002 |
0.481 |
|
| 2000 |
Rao CV, Cooma I, Rodriguez JGR, Simi B, El-Bayoumy K, Reddy BS. Chemoprevention of familial adenomatous polyposis development in the APCmin mouse model by 1,4-phenylene bis(methylene)selenocyanate Carcinogenesis. 21: 617-621. PMID 10753194 DOI: 10.1093/Carcin/21.4.617 |
0.49 |
|
| 2000 |
Reddy BS, Hirose Y, Lubet RA, Steele VE, Kelloff GJ, Rao CV. Lack of chemopreventive efficacy of DL-selenomethionine in colon carcinogenesis. International Journal of Molecular Medicine. 5: 327-30. PMID 10719045 DOI: 10.3892/IJMM.5.4.327 |
0.411 |
|
| 2000 |
Rao CV, Simi B, Hirose Y, Upadhyaya P, El-Bayoumy K, Reddy BS. Mechanisms in the chemoprevention of colon cancer: modulation of protein kinase C, tyrosine protein kinase and diacylglycerol kinase activities by 1,4-phenylenebis-(methylene)selenocyanate and impact of low-fat diet. International Journal of Oncology. 16: 519-546. PMID 10675484 DOI: 10.3892/Ijo.16.3.519 |
0.471 |
|
| 1999 |
Agarwal B, Rao CV, Bhendwal S, Ramey WR, Shirin H, Reddy BS, Holt PR. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac. Gastroenterology. 117: 838-847. PMID 10500066 DOI: 10.1016/S0016-5085(99)70342-2 |
0.434 |
|
| 1999 |
Reddy BS, Kawamori T, Lubet R, Steele V, Kelloff G, Rao CV. Chemopreventive effect of S-methylmethane thiosulfonate and sulindac administered together during the promotion/progression stages of colon carcinogenesis. Carcinogenesis. 20: 1645-8. PMID 10426822 DOI: 10.1093/Carcin/20.8.1645 |
0.403 |
|
| 1999 |
Rao CV, Kawamori T, Hamid R, Reddy BS. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis. 20: 641-4. PMID 10223193 DOI: 10.1093/CARCIN/20.4.641 |
0.4 |
|
| 1999 |
Rao CV, Sanders ME, Indranie C, Simi B, Reddy BS. Prevention of colonic preneoplastic lesions by the probiotic Lactobacillus acidophilus NCFMTM in F344 rats. International Journal of Oncology. 14: 939-983. PMID 10200345 DOI: 10.3892/Ijo.14.5.939 |
0.474 |
|
| 1998 |
Kawamori T, El-Bayoumy K, Ji B-, Rodriguez JGR, Rao CV, Reddy BS. Evaluation of benzyl selenocyanate glutathione conjugate for potential chemopreventive properties in colon carcinogenesis. International Journal of Oncology. 13: 29-34. PMID 9625800 DOI: 10.3892/Ijo.13.1.29 |
0.495 |
|
| 1998 |
Rao CV, Newmark HL, Reddy BS. Chemopreventive effect of squalene on colon cancer. Carcinogenesis. 19: 287-290. PMID 9498278 DOI: 10.1093/Carcin/19.2.287 |
0.446 |
|
| 1997 |
Reddy BS, Hamid R, Rao CV. Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition Carcinogenesis. 18: 1371-1374. PMID 9230282 DOI: 10.1093/Carcin/18.7.1371 |
0.457 |
|
| 1997 |
Reddy BS, Rivenson A, El-Bayoumy K, Upadhyaya P, Pittman B, Rao CV. Chemoprevention of colon cancer by organoselenium compounds and impact of high- or low-fat diets Journal of the National Cancer Institute. 89: 506-512. PMID 9086007 DOI: 10.1093/Jnci/89.7.506 |
0.459 |
|
| 1995 |
El‐Bayoumy K, Upadhyaya P, Chae Y, Sohn O, Rao CV, Fiala E, Reddy BS. Chemoprevention of cancer by organoselenium compounds. Journal of Cellular Biochemistry. 59: 92-100. PMID 8538214 DOI: 10.1002/Jcb.240590812 |
0.509 |
|
| 1995 |
Rao CV, Rivenson A, Simi B, Reddy BS. Chemoprevention of Colon Cancer by Dietary Curcumin Annals of the New York Academy of Sciences. 768: 201-204. PMID 8526348 DOI: 10.1111/J.1749-6632.1995.Tb12122.X |
0.467 |
|
| 1995 |
Liu T, Mokuolu AO, Rao CV, Reddy BS, Holt PR. Regional chemoprevention of carcinogen-induced tumors in rat colon Gastroenterology. 109: 1167-1172. PMID 7557082 DOI: 10.1016/0016-5085(95)90575-8 |
0.423 |
|
| 1994 |
Singh J, Rao CV, Kulkarni N, Simi B, Reddy BS. Molecular markers as intermediate end-points in chemoprevention of colon-cancer - modulation of ras activation by sulindac and phenylhexylisothiocyanate during colon carcinogenesis. International Journal of Oncology. 5: 1009-1018. PMID 21559673 DOI: 10.3892/Ijo.5.5.1009 |
0.385 |
|
| 1993 |
Reddy BS, Rao CV, Rivenson A, Kelloff G. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats Carcinogenesis. 14: 1493-1497. PMID 8353834 DOI: 10.1093/Carcin/14.8.1493 |
0.517 |
|
| 1993 |
Rao CV, Zang E, Reddy BS. Effect of high fat corn oil, olive oil and fish oil on phospholipid fatty acid composition in male F344 rats Lipids. 28: 441-447. PMID 8316053 DOI: 10.1007/Bf02535943 |
0.326 |
|
| 1993 |
Rao CV, Simi B, Reddy BS. Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon Carcinogenesis. 14: 2219-2225. PMID 8242846 DOI: 10.1093/carcin/14.11.2219 |
0.35 |
|
| 1993 |
Bartram HP, Gostner A, Scheppach W, Reddy BS, Rao CV, Dusel G, Richter F, Richter A, Kasper H. Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin E2 release in healthy subjects. Gastroenterology. 105: 1317-1322. PMID 8224635 DOI: 10.1016/0016-5085(93)90135-Y |
0.338 |
|
| 1991 |
Rao CV, Tokomo K, Kelloff G, Reddy BS. Inhibition by dietary oltipraz of experimental intestinal carcinogenesis induced by azoxymethane in male F344 rats. Carcinogenesis. 12: 1051-1056. PMID 2044183 DOI: 10.1093/Carcin/12.6.1051 |
0.457 |
|
| 1991 |
Rao CV, Nayini J, Reddy BS. Effect of Oltipraz [5-(2-Pyrazinyl)-4-methyl-1,2-dithiol-3-thione] on Azoxymethane-Induced Biochemical Changes Related to Early Colon Carcinogenesis in Male F344 Rats Proceedings of the Society For Experimental Biology and Medicine. 197: 77-84. PMID 2020672 DOI: 10.3181/00379727-197-43228 |
0.475 |
|
| Show low-probability matches. |